Structure Therapeutics (GPCR) Leases (2022 - 2026)

Quarterly Leases fell 23.34% to $5.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Mar 2026, down 23.34% year-over-year, with the annual reading at $6.2 million for FY2025, 76.66% up from the prior year.

Structure Therapeutics' Leases history spans 5 years, with the latest figure at $5.6 million for Q1 2026.

  • Leases came in at $5.6 million for Q1 2026, down from $6.2 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $7.5 million in Q2 2025 to a low of $90000.0 in Q2 2023.
  • The 5-year median for Leases is $4.5 million (2024), against an average of $4.2 million.
  • The largest YoY upside for Leases was 4641.11% in 2024 against a maximum downside of 31.17% in 2024.
  • Structure Therapeutics' Leases stood at $262000.0 in 2022, then skyrocketed by 1860.31% to $5.1 million in 2023, then crashed by 31.17% to $3.5 million in 2024, then soared by 76.66% to $6.2 million in 2025, then fell by 10.23% to $5.6 million in 2026.
  • Per Business Quant, the three most recent readings for GPCR's Leases are $5.6 million (Q1 2026), $6.2 million (Q4 2025), and $6.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 83,048.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 61,822.50
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.69 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 189.30 Mn
10 Structure Therapeutics 8.43 Bn 8.43 Bn - 5.61 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.61 Mn
Dec 31, 2025 6.25 Mn
Sep 30, 2025 6.86 Mn
Jun 30, 2025 7.48 Mn
Mar 31, 2025 7.31 Mn
Dec 31, 2024 3.54 Mn
Sep 30, 2024 4.01 Mn
Jun 30, 2024 4.27 Mn
Mar 31, 2024 4.70 Mn
Dec 31, 2023 5.14 Mn
Sep 30, 2023 3.65 Mn
Jun 30, 2023 90,000.00
Mar 31, 2023 178,000.00
Dec 31, 2022 262,000.00